Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. | BMC Cancer | 2023 | 38114959 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer. | Int J Gen Med | 2023 | 38106976 | PubTator, text mining | PubMed |
| γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids. | Front Immunol | 2023 | 38090581 | PubTator, text mining | PubMed |
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance. | Front Genet | 2023 | 38075690 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
| Genome tuning through HLA and KIR gene clusters impact susceptibility to dengue. | Infect Med (Beijing) | 2023 | 38073888 | PubTator, text mining | PubMed |
| The emerging role of glycolysis and immune evasion in gastric cancer. | Cancer Cell Int | 2023 | 38071310 | PubTator, text mining | PubMed |
| CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects. | Cells | 2023 | 38067178 | PubTator, text mining | PubMed |
| Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer. | J Transl Med | 2023 | 38062450 | PubTator, text mining | PubMed |
| Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment. | Int J Nanomedicine | 2023 | 38059000 | PubTator, text mining | PubMed |
| The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies. | Cancer Cell Int | 2023 | 38057843 | PubTator, text mining | PubMed |
| Immune system gene polymorphisms associated with severe dengue in Latin America: a systematic review. | Rev Inst Med Trop Sao Paulo | 2023 | 38055376 | PubTator, text mining | PubMed |
| Prognostic role of long non-coding RNA USP30-AS1 in ovarian cancer: insights into immune cell infiltration in the tumor microenvironment. | Aging (Albany NY) | 2023 | 38054797 | PubTator, text mining | PubMed |
| Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study. | BMC Cancer | 2023 | 38049731 | PubTator, text mining | PubMed |
| TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion. | iScience | 2023 | 38047087 | PubTator, text mining | PubMed |
| Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy. | MedComm (2020) | 2023 | 38045827 | PubTator, text mining | PubMed |
| Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. | Mol Cancer | 2023 | 38041084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=11